Commercialization: Page 18
-
PharmaVoice Team/PharmaVoice
Last Word
Unusual Times Call for Outside-the-Box Thinking Lynn O’Connor Vos, President and CEO of the Muscular Dystrophy Association, discusses the innovative approaches the organization is taking to remain connected with its population during the COVID-19 pandemic. PV: The Muscular Dystrophy Association (...
By Lynn O’Connor Vos • May 1, 2020 -
PharmaVoice Team/PharmaVoice
Marketing in the Future
The marketing landscape of tomorrow will look much different as lines continue to blur between consultancies and agencies. An April 2019 poll conducted by Digiday showed that 22% of client-side marketers planned to shift work from agencies to consulting firms. While the majority of respondents sa...
By Robin Robinson • May 1, 2020 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Connected Health & IoT: The Growing Potential of Connected IoT
In healthcare, IoT is being investigated in a wide range of areas — remote monitoring, the use of smart sensors, within medical devices, and in many pharmaceutical applications, such as smart pills and treating disease. There are few hotter or broader topics than the Internet of Things (IoT). Acc...
By PharmaVoice Team • May 1, 2020 -
PharmaVoice Team/PharmaVoice
If I Could Only Ask Two Questions, The First One Would Be: What is Your Data Integration and Analytics Platform Strategy?
It’s really simple, data analytics drives decisions. In the healthcare industry, we use data to better understand the complexity of disease, improve forecasting and communications with patients, design more effective clinical trials, predict trends, customize treatment pathways, and so much more....
By Brigham Hyde • May 1, 2020 -
PharmaVoice Team/PharmaVoice
IoT — Skunkworks Origins, Life-Changing Fruition
Before the Internet became the modern technological behemoth we know and cannot live without today, there sat a Coca-Cola vending machine at Carnegie Mellon University in Pittsburgh, Pennsylvania. Back in 1982, David Nichols, a computer science graduate student grew ever-so tired of making the tr...
By Carmine Jichetti • May 1, 2020 -
PharmaVoice Team/PharmaVoice
Programming Better Health: How the Internet of Things Can Keep Us Well
Healthcare professionals have always struggled to keep their patients healthy. The simplest steps can make a huge difference in the overall health of an individual, but the truth is, all of us are guilty of nonadherence to a variety of things. I have light excuses. I’m certainly guilty of missing...
By Gene Fitzpatrick • May 1, 2020 -
PharmaVoice Team/PharmaVoice
Mobile Brands
Mobile provides effective messaging to both physicians and patients. As the coronavirus greatly affects advertising behaviors across industries, mobile messaging remains a viable tactic for reaching both physicians and patients. According to a March report from IAB, digital ad spending is down 33...
By Robin Robinson • May 1, 2020 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Brand Building: The Changing Face of Brand Building
The number of channels that pharmaceutical marketers have open to them for brand building today is vast and each has its own requirements and benefits. Since the mid-1980s, pharmaceutical companies in the United States have been promoting their brands to the public through print, radio, and telev...
By PharmaVoice Team • May 1, 2020 -
PharmaVoice Team/PharmaVoice
Brand Building: Back to the Basics
As healthcare marketers, we are charged with the vital task of communicating the benefits of pharmaceutical therapies to the healthcare professionals (HCPs), patients, and payers we serve, with the goal of improving the health of individual patients, and more broadly, public health. The importanc...
By Gordon Olsen • May 1, 2020 -
PharmaVoice Team/PharmaVoice
The Longing for Belonging
Wanna build a healthcare brand in 2020? Whether you are launching a new product or re-positioning a brand that has perhaps gotten a little long in the tooth, consider the following: Data is out. Belonging is in. Put another way, to connect with today’s consumer, healthcare marketers must start tr...
By Toby Trygg • May 1, 2020 -
PharmaVoice Team/PharmaVoice
Patient Access: Keeping the Channel Open During a Crisis
A managed access program enables pharmaceutical and biotechnology companies to make certain investigational or unapproved treatments available to eligible patients through their prescribing physicians. But what happens when the supply chain is disrupted by a pandemic, such as COVID-19? The worldw...
By Carolyn Gretton • May 1, 2020 -
PharmaVoice Team/PharmaVoice
Commanders & Chiefs
The role of chief technology officer has become more encompassing as companies adopt new software and technology-based solutions to solve some of their biggest challenges and create opportunities for new rewards. Zaher El-Assi Decentralizing & Accelerating Trials Next-generation innovations t...
By PharmaVoice Team • May 1, 2020 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Inspiring Leadership Amid the COVID-19 global pandemic and the yet-to-be-determined devastation, it is heartening to see the heroic efforts being put forth by healthcare workers who are risking their own lives on the front lines of patient care. We are also seeing healthcare companies pivot their...
By Taren Grom • April 1, 2020 -
PharmaVoice Team/PharmaVoice
Upfront
BMS Undergoes Brand Transformation Bristol Myers Squibb has revealed a new brand to reflect its evolution in light of its acquisition of Celgene for $74 billion late last year. The changes reflect an updated website, logo, and a change in punctuation — removing the hyphen between Bristol and Myer...
By PharmaVoice Team • April 1, 2020 -
PharmaVoice Team/PharmaVoice
HealthTech
Boehringer-Ingelheim Launches Patient-Centric MyStudyWindow Powered by Carebox Trend Watch: HealthTech Innovations Continue to Transform Patient Care Boehringer Ingelheim and Carebox Healthcare Solutions have launched MyStudyWindow, a digital platform empowering patients, families, caregivers, an...
By PharmaVoice Team • April 1, 2020 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence
Microsoft Launches $40M Healthcare Artificial Intelligence Program Trend Watch: AI continues to gain traction worldwide in healthcare and pharma applications Microsoft has launched a 5-year, $40 million program called AI for Health, an initiative that will use artificial intelligence tools to add...
By PharmaVoice Team • April 1, 2020 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
COVID-19 The latest drug and vaccine innovations to counter this deadly virus. The rapidly moving target of the coronavirus is challenging the best of the world’s life-sciences innovators, and the landscape changes not only by the day but by the hour. At press time for this issue, these are the m...
By PharmaVoice Team • April 1, 2020 -
PharmaVoice Team/PharmaVoice
Brand Bonds: Agency-Client Relationships
Three successful agency and client teams discuss the importance of a positive working relationship. The Chemistry Click Brian Peters Medexus Pharma Having chemistry with people during the agency selection process is most important. If you don’t have that personal connection, it just becomes work,...
By Robin Robinson • April 1, 2020 -
PharmaVoice Team/PharmaVoice
Commanders & Chiefs: Chief Digital Officers
More and more companies are elevating the role of chief digital officer to oversee a range of strategies and the integration of technology solutions. Nagaraja Srivatsan Data in Use The biggest trend I am tracking is determining how data can be used effectively to make critical and impactful decis...
By Nagaraja Srivatsan • April 1, 2020 -
PharmaVoice Team/PharmaVoice
Executive Perspective: Bioinformatics Is Changing the Face of Discovery and Development: A Conversation with Bill Moss, CEO, Seven Bridges
While the rate of approval of novel life-changing precision medicines is on the rise, the economics facing those who discover, commercialize, and are in need of such medications are untenable. The combination of the increased development costs and more narrowly targeted patient populations of pre...
By Bill Moss • April 1, 2020 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The patient experience We are excited to publish the third annual Patient Voice issue. This special publication is dedicated to raising the voice of patients and sharing their insights on topics ranging from drug discovery and development through commercialization. We also have tapped nearly 100 ...
By Taren Grom • March 1, 2020 -
PharmaVoice Team/PharmaVoice
Upfront
Teva and Direct Relief Partner to Bring Cancer Medicines to Africa Global HOPE (Hematology-Oncology Pediatric Excellence), a program of Texas Children’s Hospital, Teva Pharmaceutical Industries, and Direct Relief are partnering to provide access to medications in sub-Saharan Africa, where a major...
By PharmaVoice Team • March 1, 2020 -
PharmaVoice Team/PharmaVoice
HealthTech
Apple Working on Preventative Healthcare Technology Trend Watch: Mobile Devices Expand Healthcare Monitoring Capabilities In January, Apple CEO Tim Cook announced the company is investigating in technology that could help identify health risks at an early stage, similar to heart monitoring featur...
By PharmaVoice Team • March 1, 2020 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence
AI-Based Blood Test Predicts Neurodegenerative Disease Progression Trend Watch: AI continues to enhance testing, prediction, and diagnosis A new study illustrates that analysis of blood samples through the use of artificial intelligence can be used to predict disease progression. Researchers at T...
By PharmaVoice Team • March 1, 2020 -
PharmaVoice Team/PharmaVoice
Last Word
USP: 200 Years of Building Trust Ronald Piervincenzi, Ph.D., who has served as CEO of the United States Pharmacopeia (USP) since February 2014, discusses the organization’s evolution over the past 200 years and its strategy for the future. PV: Congratulations on the 200th anniversary of USP. How ...
By Ronald Piervincenzi • March 1, 2020
Previous
